TMS Related Biomarker Assessments
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Patients with schizophrenia spectrum disorder (SSD) will be exposed to active and sham repetitive transcranial magnetic stimulation (rTMS) in separate sessions. SSD-related biomarkers will be assessed before and after the rTMS administration.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:
• Male and Female between ages 18-65
• Ability to give written informed consent (age 18 or above)
• Diagnosed with schizophrenia-spectrum disorder and Evaluation to Sign Consent (ESC) above10.
Locations
United States
Maryland
University of Maryland, Baltimore
RECRUITING
Baltimore
Contact Information
Primary
Xiaoming Du, PhD
xdu@som.umaryland.edu
410-402-6036
Backup
Kimberly Tate
410-402-6008
Time Frame
Start Date: 2023-01-07
Estimated Completion Date: 2028-12
Participants
Target number of participants: 60
Treatments
Other: Active rTMS first and sham rTMS second
Participants in this arm will receive active rTMS in one visit first, then receive sham rTMS in another visit.
Other: Sham rTMS first and active rTMS second
Participants in this arm will receive sham rTMS in one visit first, then receive active rTMS in another visit.
Related Therapeutic Areas
Sponsors
Leads: University of Maryland, Baltimore